封面
市場調查報告書
商品編碼
2018296

醫療領域生成式人工智慧市場規模、佔有率和趨勢分析報告:按組件、功能、最終用途、應用、地區和細分市場分類,預測至2026-2033年

Generative AI In Healthcare Market Size, Share & Trends Analysis Report By Component (Solutions), By Function (Virtual Nursing Assistants), By End Use (Clinical Research), By Application (Clinical), By Region, And Segment Forecasts, 2026 - 2033

出版日期: | 出版商: Grand View Research | 英文 120 Pages | 商品交期: 2-10個工作天內

價格

醫療領域生成式人工智慧市場概述

2025年全球醫療領域生成式人工智慧市場規模估計為29億美元,預計2033年將達282億美元。

預計從 2026 年到 2033 年,生成式人工智慧將以 33.3% 的複合年成長率成長。生成式人工智慧透過提供數據驅動的洞察,改善患者照護、提高診斷準確性並簡化臨床工作流程,從而改變醫療保健領域。

此外,患者數量的增加、人口老化以及醫療數據的日益複雜化,都在推動醫療保健市場對人工智慧的需求。

目錄

第1章:調查方法和範圍

第2章執行摘要

第3章 醫療領域生成式人工智慧市場:變數、趨勢與範圍

  • 市場譜系展望
  • 市場動態
  • 醫療領域生成式人工智慧的市場分析工具
  • 用例分析

第4章:醫療領域生成式人工智慧市場:按組件分類的估算與趨勢分析

  • 醫療領域生成式人工智慧市場:基於組件的波動分析(2025-2033 年)
  • 解決方案
  • 服務

第5章:醫療領域生成式人工智慧市場:功能分析、估算與趨勢

  • 醫療領域生成式人工智慧市場:功能波動分析(2025-2033 年)
  • 虛擬護理助理
  • 機器人輔助人工智慧手術
  • 管理流程最佳化
  • 醫學影像分析

第6章:醫療領域生成式人工智慧市場:按最終用途分類的估算與趨勢分析

  • 醫療領域生成式人工智慧市場:按最終用途分類的波動分析(2025-2033 年)
  • 臨床研究
  • 醫療中心
  • 診斷中心
  • 其他

第7章:醫療領域生成式人工智慧市場:按應用分類的估算與趨勢分析

  • 醫療領域生成式人工智慧市場:基於應用的波動分析(2025-2033)
  • 臨床
  • 系統

第8章:醫療領域生成式人工智慧市場:區域估算與趨勢分析

  • 區域市場佔有率分析(2025 年和 2033 年)
  • 區域市場概覽
  • 市場規模、預測與趨勢分析,2021-2033年
  • 北美洲
    • 美國
    • 加拿大
    • 墨西哥
  • 歐洲
    • 英國
    • 德國
    • 法國
    • 義大利
    • 西班牙
    • 挪威
    • 瑞典
    • 丹麥
  • 亞太地區
    • 日本
    • 中國
    • 印度
    • 澳洲
    • 韓國
    • 泰國
  • 拉丁美洲
    • 巴西
    • 阿根廷
  • 中東和非洲
    • 南非
    • 沙烏地阿拉伯
    • UAE
    • 科威特

第9章 競爭情勢

  • 公司和競爭對手的分類
  • 策略規劃
  • 2025年公司市場分析
  • 公司簡介列表
    • NVIDIA Corporation
    • Google LLC
    • IBM
    • Johnson & Johnson
    • Microsoft Corporation
    • Oracle
    • Tencent Holdings Ltd
    • Neuralink Corporation
    • NioyaTech
    • OpenAI
    • Saxon
    • Syntegra
Product Code: GVR-4-68040-135-7

Generative AI In Healthcare Market Summary

The global generative AI in healthcare market size was estimated at USD 2.9 billion in 2025 and is projected to reach USD 28.2 billion by 2033, growing at a CAGR of 33.3% from 2026 to 2033. Generative AI is transforming healthcare by providing data-driven insights that improve patient care, enhance diagnostic accuracy, and streamline clinical workflows.

Moreover, the rising patient volumes, an aging population, and the increasing complexity of medical data are increasing the demand for AI in the healthcare market.

Global Generative AI In Healthcare Market Report Segmentation

This report forecasts revenue growth at the global, regional, and country levels and provides an analysis of the industry trends in each of the sub-segments from 2021 to 2033. For this study, Grand View Research has segmented the generative AI in healthcare market report based on component, function, end use, application, and region:

  • Component Outlook (Revenue, USD Million, 2021 - 2033)
  • Solutions
  • Service
  • Function Outlook (Revenue, USD Million, 2021 - 2033)
  • Virtual Nursing Assistants
  • Robot-Assisted AI Surgery
  • Administrative Process Optimization
  • Medical Imaging Analysis
  • End Use Outlook (Revenue, USD Million, 2021 - 2033)
  • Clinical Research
  • Medical Centers
  • Diagnostic Centers
  • Others
  • Application Outlook (Revenue, USD Million, 2021 - 2033)
  • Clinical
  • System
  • Regional Outlook (Revenue, USD Million, 2021 - 2033)
  • North America
    • U.S.
    • Canada
    • Mexico
  • Europe
    • Germany
    • UK
    • France
    • Italy
    • Spain
    • Denmark
    • Sweden
    • Norway
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Australia
    • Thailand
  • Latin America
    • Brazil
    • Argentina
  • Middle East and Africa
    • Saudi Arabia
    • UAE
    • South Africa
    • Kuwait

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation & Scope
  • 1.2. Market Definitions
    • 1.2.1. Component Segment
    • 1.2.2. Function Segment
    • 1.2.3. Application
    • 1.2.4. End Use
  • 1.3. Information analysis
    • 1.3.1. Market formulation & data visualization
  • 1.4. Data validation & publishing
  • 1.5. Information Procurement
    • 1.5.1. Primary Research
  • 1.6. Information or Data Analysis
  • 1.7. Market Formulation & Validation
  • 1.8. Market Model
  • 1.9. Total Market: CAGR Calculation
  • 1.10. Objectives
    • 1.10.1. Objective 1
    • 1.10.2. Objective 2

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Outlook
  • 2.3. Competitive Insights

Chapter 3. Generative AI in Healthcare Market Variables, Trends, & Scope

  • 3.1. Market Lineage Outlook
  • 3.2. Market Dynamics
    • 3.2.1. Market Driver Analysis
    • 3.2.2. Market Restraint Analysis
    • 3.2.3. Industry Challenge Analysis
    • 3.2.4. Industry Opportunity Analysis
  • 3.3. Generative AI in Healthcare Market Analysis Tools
    • 3.3.1. Industry Analysis - Porter's Five Forces Analysis
      • 3.3.1.1. Bargaining power of the suppliers
      • 3.3.1.2. Bargaining power of the buyers
      • 3.3.1.3. Threats of substitution
      • 3.3.1.4. Threats from new entrants
      • 3.3.1.5. Competitive rivalry
    • 3.3.2. PESTEL Analysis
      • 3.3.2.1. Political Landscape
      • 3.3.2.2. Economic Landscape
      • 3.3.2.3. Social Landscape
      • 3.3.2.4. Technology Landscape
      • 3.3.2.5. Environmental Landscape
      • 3.3.2.6. Legal Landscape
  • 3.4. Use Cases Analysis

Chapter 4. Generative AI in Healthcare Market: Component Estimates & Trend Analysis

  • 4.1. Segment Dashboard
  • 4.2. Generative AI in Healthcare Market: Component Movement Analysis, USD Million, 2025 & 2033
  • 4.3. Solutions
    • 4.3.1. Solutions Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 4.4. Services
    • 4.4.1. Services Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)

Chapter 5. Generative AI in Healthcare Market: Function Estimates & Trend Analysis

  • 5.1. Segment Dashboard
  • 5.2. Generative AI in Healthcare Market: Function Movement Analysis, USD Million, 2025 & 2033
  • 5.3. Virtual Nursing Assistants
    • 5.3.1. Virtual Nursing Assistants Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 5.4. Robot-Assisted AI Surgery
    • 5.4.1. Robot-Assisted AI Surgery Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 5.5. Administrative Process Optimization
    • 5.5.1. Administrative Process Optimization Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 5.6. Medical Imaging Analysis
    • 5.6.1. Medical Imaging Analysis Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)

Chapter 6. Generative AI in Healthcare Market: End Use Estimates & Trend Analysis

  • 6.1. Segment Dashboard
  • 6.2. Generative AI in Healthcare Market: End Use Movement Analysis, USD Million, 2025 & 2033
  • 6.3. Clinical Research
    • 6.3.1. Clinical Research Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 6.4. Medical Centers
    • 6.4.1. Medical Centers Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 6.5. Diagnostic Centers
    • 6.5.1. Diagnostic Centers Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 6.6. Others
    • 6.6.1. Others Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)

Chapter 7. Generative AI in Healthcare Market: Application Estimates & Trend Analysis

  • 7.1. Segment Dashboard
  • 7.2. Generative AI in Healthcare Market: Application Movement Analysis, USD Million, 2025 & 2033
  • 7.3. Clinical
    • 7.3.1. Clinical Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 7.4. System
    • 7.4.1. System Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)

Chapter 8. Generative AI in Healthcare Market: Regional Estimates & Trend Analysis

  • 8.1. Regional Market Share Analysis, 2025 & 2033
  • 8.2. Regional Market Dashboard
  • 8.3. Market Size & Forecasts Trend Analysis, 2021 to 2033:
  • 8.4. North America
    • 8.4.1. U.S.
      • 8.4.1.1. Key country dynamics
      • 8.4.1.2. Regulatory framework
      • 8.4.1.3. Competitive scenario
      • 8.4.1.4. U.S. market estimates and forecasts, 2021 to 2033 (USD Million)
    • 8.4.2. Canada
      • 8.4.2.1. Key country dynamics
      • 8.4.2.2. Regulatory framework
      • 8.4.2.3. Competitive scenario
      • 8.4.2.4. Canada market estimates and forecasts, 2021 to 2033 (USD Million)
    • 8.4.3. Mexico
      • 8.4.3.1. Key country dynamics
      • 8.4.3.2. Regulatory framework
      • 8.4.3.3. Competitive scenario
      • 8.4.3.4. Mexico market estimates and forecasts, 2021 to 2033 (USD Million)
  • 8.5. Europe
    • 8.5.1. UK
      • 8.5.1.1. Key country dynamics
      • 8.5.1.2. Regulatory framework
      • 8.5.1.3. Competitive scenario
      • 8.5.1.4. UK market estimates and forecasts, 2021 to 2033 (USD Million)
    • 8.5.2. Germany
      • 8.5.2.1. Key country dynamics
      • 8.5.2.2. Regulatory framework
      • 8.5.2.3. Competitive scenario
      • 8.5.2.4. Germany market estimates and forecasts, 2021 to 2033 (USD Million)
    • 8.5.3. France
      • 8.5.3.1. Key country dynamics
      • 8.5.3.2. Regulatory framework
      • 8.5.3.3. Competitive scenario
      • 8.5.3.4. France market estimates and forecasts, 2021 to 2033 (USD Million)
    • 8.5.4. Italy
      • 8.5.4.1. Key country dynamics
      • 8.5.4.2. Regulatory framework
      • 8.5.4.3. Competitive scenario
      • 8.5.4.4. Italy market estimates and forecasts, 2021 to 2033 (USD Million)
    • 8.5.5. Spain
      • 8.5.5.1. Key country dynamics
      • 8.5.5.2. Regulatory framework
      • 8.5.5.3. Competitive scenario
      • 8.5.5.4. Spain market estimates and forecasts, 2021 to 2033 (USD Million)
    • 8.5.6. Norway
      • 8.5.6.1. Key country dynamics
      • 8.5.6.2. Regulatory framework
      • 8.5.6.3. Competitive scenario
      • 8.5.6.4. Norway market estimates and forecasts, 2021 to 2033 (USD Million)
    • 8.5.7. Sweden
      • 8.5.7.1. Key country dynamics
      • 8.5.7.2. Regulatory framework
      • 8.5.7.3. Competitive scenario
      • 8.5.7.4. Sweden market estimates and forecasts, 2021 to 2033 (USD Million)
    • 8.5.8. Denmark
      • 8.5.8.1. Key country dynamics
      • 8.5.8.2. Regulatory framework
      • 8.5.8.3. Competitive scenario
      • 8.5.8.4. Denmark market estimates and forecasts, 2021 to 2033 (USD Million)
  • 8.6. Asia Pacific
    • 8.6.1. Japan
      • 8.6.1.1. Key country dynamics
      • 8.6.1.2. Regulatory framework
      • 8.6.1.3. Competitive scenario
      • 8.6.1.4. Japan market estimates and forecasts, 2021 to 2033 (USD Million)
    • 8.6.2. China
      • 8.6.2.1. Key country dynamics
      • 8.6.2.2. Regulatory framework
      • 8.6.2.3. Competitive scenario
      • 8.6.2.4. China market estimates and forecasts, 2021 to 2033 (USD Million)
    • 8.6.3. India
      • 8.6.3.1. Key country dynamics
      • 8.6.3.2. Regulatory framework
      • 8.6.3.3. Competitive scenario
      • 8.6.3.4. India market estimates and forecasts, 2021 to 2033 (USD Million)
    • 8.6.4. Australia
      • 8.6.4.1. Key country dynamics
      • 8.6.4.2. Regulatory framework
      • 8.6.4.3. Competitive scenario
      • 8.6.4.4. Australia market estimates and forecasts, 2021 to 2033 (USD Million)
    • 8.6.5. South Korea
      • 8.6.5.1. Key country dynamics
      • 8.6.5.2. Regulatory framework
      • 8.6.5.3. Competitive scenario
      • 8.6.5.4. South Korea market estimates and forecasts, 2021 to 2033 (USD Million)
    • 8.6.6. Thailand
      • 8.6.6.1. Key country dynamics
      • 8.6.6.2. Regulatory framework
      • 8.6.6.3. Competitive scenario
      • 8.6.6.4. Thailand market estimates and forecasts, 2021 to 2033 (USD Million)
  • 8.7. Latin America
    • 8.7.1. Brazil
      • 8.7.1.1. Key country dynamics
      • 8.7.1.2. Regulatory framework
      • 8.7.1.3. Competitive scenario
      • 8.7.1.4. Brazil market estimates and forecasts, 2021 to 2033 (USD Million)
    • 8.7.2. Argentina
      • 8.7.2.1. Key country dynamics
      • 8.7.2.2. Regulatory framework
      • 8.7.2.3. Competitive scenario
      • 8.7.2.4. Argentina market estimates and forecasts, 2021 to 2033 (USD Million)
  • 8.8. MEA
    • 8.8.1. South Africa
      • 8.8.1.1. Key country dynamics
      • 8.8.1.2. Regulatory framework
      • 8.8.1.3. Competitive scenario
      • 8.8.1.4. South Africa market estimates and forecasts, 2021 to 2033 (USD Million)
    • 8.8.2. Saudi Arabia
      • 8.8.2.1. Key country dynamics
      • 8.8.2.2. Regulatory framework
      • 8.8.2.3. Competitive scenario
      • 8.8.2.4. Saudi Arabia market estimates and forecasts, 2021 to 2033 (USD Million)
    • 8.8.3. UAE
      • 8.8.3.1. Key country dynamics
      • 8.8.3.2. Regulatory framework
      • 8.8.3.3. Competitive scenario
      • 8.8.3.4. UAE market estimates and forecasts, 2021 to 2033 (USD Million)
    • 8.8.4. Kuwait
      • 8.8.4.1. Key country dynamics
      • 8.8.4.2. Regulatory framework
      • 8.8.4.3. Competitive scenario
      • 8.8.4.4. Kuwait market estimates and forecasts, 2021 to 2033 (USD Million)

Chapter 9. Competitive Landscape

  • 9.1. Company/Competition Categorization
  • 9.2. Strategy Mapping
  • 9.3. Company Market Position Analysis, 2025
  • 9.4. Company Profiles/Listing
    • 9.4.1. NVIDIA Corporation
      • 9.4.1.1. Company overview
      • 9.4.1.2. Financial performance
      • 9.4.1.3. Product benchmarking
      • 9.4.1.4. Strategic initiatives
    • 9.4.2. Google LLC
      • 9.4.2.1. Company overview
      • 9.4.2.2. Financial performance
      • 9.4.2.3. Product benchmarking
      • 9.4.2.4. Strategic initiatives
    • 9.4.3. IBM
      • 9.4.3.1. Company overview
      • 9.4.3.2. Financial performance
      • 9.4.3.3. Product benchmarking
      • 9.4.3.4. Strategic initiatives
    • 9.4.4. Johnson & Johnson
      • 9.4.4.1. Company overview
      • 9.4.4.2. Financial performance
      • 9.4.4.3. Product benchmarking
      • 9.4.4.4. Strategic initiatives
    • 9.4.5. Microsoft Corporation
      • 9.4.5.1. Company overview
      • 9.4.5.2. Financial performance
      • 9.4.5.3. Product benchmarking
      • 9.4.5.4. Strategic initiatives
    • 9.4.6. Oracle
      • 9.4.6.1. Company overview
      • 9.4.6.2. Financial performance
      • 9.4.6.3. Product benchmarking
      • 9.4.6.4. Strategic initiatives
    • 9.4.7. Tencent Holdings Ltd
      • 9.4.7.1. Company overview
      • 9.4.7.2. Financial performance
      • 9.4.7.3. Product benchmarking
      • 9.4.7.4. Strategic initiatives
    • 9.4.8. Neuralink Corporation
      • 9.4.8.1. Company overview
      • 9.4.8.2. Financial performance
      • 9.4.8.3. Product benchmarking
      • 9.4.8.4. Strategic initiatives
    • 9.4.9. NioyaTech
      • 9.4.9.1. Company overview
      • 9.4.9.2. Financial performance
      • 9.4.9.3. Product benchmarking
      • 9.4.9.4. Strategic initiatives
    • 9.4.10. OpenAI
      • 9.4.10.1. Company overview
      • 9.4.10.2. Financial performance
      • 9.4.10.3. Product benchmarking
      • 9.4.10.4. Strategic initiatives
    • 9.4.11. Saxon
      • 9.4.11.1. Company overview
      • 9.4.11.2. Financial performance
      • 9.4.11.3. Product benchmarking
      • 9.4.11.4. Strategic initiatives
    • 9.4.12. Syntegra
      • 9.4.12.1. Company overview
      • 9.4.12.2. Financial performance
      • 9.4.12.3. Product benchmarking
      • 9.4.12.4. Strategic initiatives

List of Tables

  • Table 1 List of abbreviations
  • Table 2 Global Generative AI in Healthcare market, by region, 2021 - 2033 (USD Million)
  • Table 3 Global Generative AI in Healthcare market, by component, 2021 - 2033 (USD Million)
  • Table 4 Global Generative AI in Healthcare market, by function, 2021 - 2033 (USD Million)
  • Table 5 Global Generative AI in Healthcare market, by end use, 2021 - 2033 (USD Million)
  • Table 6 Global Generative AI in Healthcare market, by application, 2021 - 2033 (USD Million)
  • Table 7 North America Generative AI in Healthcare market, by country, 2021 - 2033 (USD Million)
  • Table 8 North America Generative AI in Healthcare market, by component, 2021 - 2033 (USD Million)
  • Table 9 North America Generative AI in Healthcare market, by function, 2021 - 2033 (USD Million)
  • Table 10 North America Generative AI in Healthcare market, by end use, 2021 - 2033 (USD Million)
  • Table 11 North America Generative AI in Healthcare market, by application, 2021 - 2033 (USD Million)
  • Table 12 U.S. Generative AI in Healthcare market, by component, 2021 - 2033 (USD Million)
  • Table 13 U.S. Generative AI in Healthcare market, by function, 2021 - 2033 (USD Million)
  • Table 14 U.S. Generative AI in Healthcare market, by end use, 2021 - 2033 (USD Million)
  • Table 15 U.S. Generative AI in Healthcare market, by application, 2021 - 2033 (USD Million)
  • Table 16 Canada Generative AI in Healthcare market, by component, 2021 - 2033 (USD Million)
  • Table 17 Canada Generative AI in Healthcare market, by function, 2021 - 2033 (USD Million)
  • Table 18 Canada Generative AI in Healthcare market, by end use, 2021 - 2033 (USD Million)
  • Table 19 Canada Generative AI in Healthcare market, by application, 2021 - 2033 (USD Million)
  • Table 20 Mexico Generative AI in Healthcare market, by component, 2021 - 2033 (USD Million)
  • Table 21 Mexico Generative AI in Healthcare market, by function, 2021 - 2033 (USD Million)
  • Table 22 Mexico Generative AI in Healthcare market, by end use, 2021 - 2033 (USD Million)
  • Table 23 Mexico Generative AI in Healthcare market, by application, 2021 - 2033 (USD Million)
  • Table 24 Europe Generative AI in Healthcare market, by country, 2021 - 2033 (USD Million)
  • Table 25 Europe Generative AI in Healthcare market, by component, 2021 - 2033 (USD Million)
  • Table 26 Europe Generative AI in Healthcare market, by function, 2021 - 2033 (USD Million)
  • Table 27 Europe Generative AI in Healthcare market, by end use, 2021 - 2033 (USD Million)
  • Table 28 Europe Generative AI in Healthcare market, by application, 2021 - 2033 (USD Million)
  • Table 29 UK Generative AI in Healthcare market, by component, 2021 - 2033 (USD Million)
  • Table 30 UK Generative AI in Healthcare market, by function, 2021 - 2033 (USD Million)
  • Table 31 UK Generative AI in Healthcare market, by end use, 2021 - 2033 (USD Million)
  • Table 32 UK Generative AI in Healthcare market, by application, 2021 - 2033 (USD Million)
  • Table 33 Germany Generative AI in Healthcare market, by component, 2021 - 2033 (USD Million)
  • Table 34 Germany Generative AI in Healthcare market, by function, 2021 - 2033 (USD Million)
  • Table 35 Germany Generative AI in Healthcare market, by end use, 2021 - 2033 (USD Million)
  • Table 36 Germany Generative AI in Healthcare market, by application, 2021 - 2033 (USD Million)
  • Table 37 France Generative AI in Healthcare market, by component, 2021 - 2033 (USD Million)
  • Table 38 France Generative AI in Healthcare market, by function, 2021 - 2033 (USD Million)
  • Table 39 France Generative AI in Healthcare market, by end use, 2021 - 2033 (USD Million)
  • Table 40 France Generative AI in Healthcare market, by application, 2021 - 2033 (USD Million)
  • Table 41 Italy Generative AI in Healthcare market, by component, 2021 - 2033 (USD Million)
  • Table 42 Italy Generative AI in Healthcare market, by function, 2021 - 2033 (USD Million)
  • Table 43 Italy Generative AI in Healthcare market, by end use, 2021 - 2033 (USD Million)
  • Table 44 Italy Generative AI in Healthcare market, by application, 2021 - 2033 (USD Million)
  • Table 45 Spain Generative AI in Healthcare market, by component, 2021 - 2033 (USD Million)
  • Table 46 Spain Generative AI in Healthcare market, by function, 2021 - 2033 (USD Million)
  • Table 47 Spain Generative AI in Healthcare market, by end use, 2021 - 2033 (USD Million)
  • Table 48 Spain Generative AI in Healthcare market, by application, 2021 - 2033 (USD Million)
  • Table 49 Denmark Generative AI in Healthcare market, by component, 2021 - 2033 (USD Million)
  • Table 50 Denmark Generative AI in Healthcare market, by function, 2021 - 2033 (USD Million)
  • Table 51 Denmark Generative AI in Healthcare market, by end use, 2021 - 2033 (USD Million)
  • Table 52 Denmark Generative AI in Healthcare market, by application, 2021 - 2033 (USD Million)
  • Table 53 Sweden Generative AI in Healthcare market, by component, 2021 - 2033 (USD Million)
  • Table 54 Sweden Generative AI in Healthcare market, by function, 2021 - 2033 (USD Million)
  • Table 55 Sweden Generative AI in Healthcare market, by end use, 2021 - 2033 (USD Million)
  • Table 56 Sweden Generative AI in Healthcare market, by application, 2021 - 2033 (USD Million)
  • Table 57 Norway Generative AI in Healthcare market, by component, 2021 - 2033 (USD Million)
  • Table 58 Norway Generative AI in Healthcare market, by function, 2021 - 2033 (USD Million)
  • Table 59 Norway Generative AI in Healthcare market, by end use, 2021 - 2033 (USD Million)
  • Table 60 Norway Generative AI in Healthcare market, by application, 2021 - 2033 (USD Million)
  • Table 61 Asia Pacific Generative AI in Healthcare market, by country, 2021 - 2033 (USD Million)
  • Table 62 Asia Pacific Generative AI in Healthcare market, by component, 2021 - 2033 (USD Million)
  • Table 63 Asia Pacific Generative AI in Healthcare market, by function, 2021 - 2033 (USD Million)
  • Table 64 Asia Pacific Generative AI in Healthcare market, by end use, 2021 - 2033 (USD Million)
  • Table 65 Asia Pacific Generative AI in Healthcare market, by application, 2021 - 2033 (USD Million)
  • Table 66 China Generative AI in Healthcare market, by component, 2021 - 2033 (USD Million)
  • Table 67 China Generative AI in Healthcare market, by function, 2021 - 2033 (USD Million)
  • Table 68 China Generative AI in Healthcare market, by end use, 2021 - 2033 (USD Million)
  • Table 69 China Generative AI in Healthcare market, by application, 2021 - 2033 (USD Million)
  • Table 70 Japan Generative AI in Healthcare market, by component, 2021 - 2033 (USD Million)
  • Table 71 Japan Generative AI in Healthcare market, by function, 2021 - 2033 (USD Million)
  • Table 72 Japan Generative AI in Healthcare market, by end use, 2021 - 2033 (USD Million)
  • Table 73 Japan Generative AI in Healthcare market, by application, 2021 - 2033 (USD Million)
  • Table 74 India Generative AI in Healthcare market, by component, 2021 - 2033 (USD Million)
  • Table 75 India Generative AI in Healthcare market, by function, 2021 - 2033 (USD Million)
  • Table 76 India Generative AI in Healthcare market, by end use, 2021 - 2033 (USD Million)
  • Table 77 India Generative AI in Healthcare market, by application, 2021 - 2033 (USD Million)
  • Table 78 South Korea Generative AI in Healthcare market, by component, 2021 - 2033 (USD Million)
  • Table 79 South Korea Generative AI in Healthcare market, by function, 2021 - 2033 (USD Million)
  • Table 80 South Korea Generative AI in Healthcare market, by end use, 2021 - 2033 (USD Million)
  • Table 81 South Korea Generative AI in Healthcare market, by application, 2021 - 2033 (USD Million)
  • Table 82 Australia Generative AI in Healthcare market, by component, 2021 - 2033 (USD Million)
  • Table 83 Australia Generative AI in Healthcare market, by function, 2021 - 2033 (USD Million)
  • Table 84 Australia Generative AI in Healthcare market, by end use, 2021 - 2033 (USD Million)
  • Table 85 Australia Generative AI in Healthcare market, by application, 2021 - 2033 (USD Million)
  • Table 86 Thailand Generative AI in Healthcare market, by component, 2021 - 2033 (USD Million)
  • Table 87 Thailand Generative AI in Healthcare market, by function, 2021 - 2033 (USD Million)
  • Table 88 Thailand Generative AI in Healthcare market, by end use, 2021 - 2033 (USD Million)
  • Table 89 Thailand Generative AI in Healthcare market, by application, 2021 - 2033 (USD Million)
  • Table 90 Latin America Generative AI in Healthcare market, by country, 2021 - 2033 (USD Million)
  • Table 91 Latin America Generative AI in Healthcare market, by component, 2021 - 2033 (USD Million)
  • Table 92 Latin America Generative AI in Healthcare market, by function, 2021 - 2033 (USD Million)
  • Table 93 Latin America Generative AI in Healthcare market, by end use, 2021 - 2033 (USD Million)
  • Table 94 Latin America Generative AI in Healthcare market, by application, 2021 - 2033 (USD Million)
  • Table 95 Brazil Generative AI in Healthcare market, by component, 2021 - 2033 (USD Million)
  • Table 96 Brazil Generative AI in Healthcare market, by function, 2021 - 2033 (USD Million)
  • Table 97 Brazil Generative AI in Healthcare market, by end use, 2021 - 2033 (USD Million)
  • Table 98 Brazil Generative AI in Healthcare market, by application, 2021 - 2033 (USD Million)
  • Table 99 Argentina Generative AI in Healthcare market, by component, 2021 - 2033 (USD Million)
  • Table 100 Argentina Generative AI in Healthcare market, by function, 2021 - 2033 (USD Million)
  • Table 101 Argentina Generative AI in Healthcare market, by end use, 2021 - 2033 (USD Million)
  • Table 102 Argentina Generative AI in Healthcare market, by application, 2021 - 2033 (USD Million)
  • Table 103 Middle East & Africa Generative AI in Healthcare market, by country, 2021 - 2033 (USD Million)
  • Table 104 Middle East & Africa Generative AI in Healthcare market, by component, 2021 - 2033 (USD Million)
  • Table 105 Middle East & Africa Generative AI in Healthcare market, by function, 2021 - 2033 (USD Million)
  • Table 106 Middle East & Africa Generative AI in Healthcare market, by end use, 2021 - 2033 (USD Million)
  • Table 107 Middle East & Africa Generative AI in Healthcare market, by application, 2021 - 2033 (USD Million)
  • Table 108 South Africa Generative AI in Healthcare market, by component, 2021 - 2033 (USD Million)
  • Table 109 South Africa Generative AI in Healthcare market, by function, 2021 - 2033 (USD Million)
  • Table 110 South Africa Generative AI in Healthcare market, by end use, 2021 - 2033 (USD Million)
  • Table 111 South Africa Generative AI in Healthcare market, by application, 2021 - 2033 (USD Million)
  • Table 112 Saudi Arabia Generative AI in Healthcare market, by component, 2021 - 2033 (USD Million)
  • Table 113 Saudi Arabia Generative AI in Healthcare market, by function, 2021 - 2033 (USD Million)
  • Table 114 Saudi Arabia Generative AI in Healthcare market, by end use, 2021 - 2033 (USD Million)
  • Table 115 Saudi Arabia Generative AI in Healthcare market, by application, 2021 - 2033 (USD Million)
  • Table 116 UAE Generative AI in Healthcare market, by component, 2021 - 2033 (USD Million)
  • Table 117 UAE Generative AI in Healthcare market, by function, 2021 - 2033 (USD Million)
  • Table 118 UAE Generative AI in Healthcare market, by end use, 2021 - 2033 (USD Million)
  • Table 119 UAE Generative AI in Healthcare market, by application, 2021 - 2033 (USD Million)
  • Table 120 Kuwait Generative AI in Healthcare market, by component, 2021 - 2033 (USD Million)
  • Table 121 Kuwait Generative AI in Healthcare market, by function, 2021 - 2033 (USD Million)
  • Table 122 Kuwait Generative AI in Healthcare market, by end use, 2021 - 2033 (USD Million)
  • Table 123 Kuwait Generative AI in Healthcare market, by application, 2021 - 2033 (USD Million)

List of Figures

  • Fig. 1 Market research process
  • Fig. 2 Data triangulation techniques
  • Fig. 3 Market formulation & validation
  • Fig. 4 Generative AI in Healthcare market: Market outlook
  • Fig. 5 Generative AI in Healthcare market: Segment outlook
  • Fig. 6 Generative AI in Healthcare market: Competitive landscape outlook
  • Fig. 7 Parent market outlook
  • Fig. 8 Generative AI in Healthcare market driver impact
  • Fig. 9 Generative AI in Healthcare market restraint impact
  • Fig. 10 Generative AI in Healthcare market: Component outlook and key takeaways
  • Fig. 11 Generative AI in Healthcare market: Component movement analysis
  • Fig. 12 Solutions market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 13 Service market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 14 Generative AI in Healthcare market: Function outlook and key takeaways
  • Fig. 15 Generative AI in Healthcare market: Function movement analysis
  • Fig. 16 Virtual Nursing Assistants market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 17 Robot-Assisted AI Surgery market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 18 Administrative Process Optimization market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 19 Medical Imaging Analysis market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 20 Generative AI in Healthcare market: End-use outlook and key takeaways
  • Fig. 21 Generative AI in Healthcare market: End-use movement analysis
  • Fig. 22 Clinical Research market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 23 Medical Centers market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 24 Diagnostic Centers market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 25 Others market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 26 Generative AI in Healthcare market: Application outlook and key takeaways
  • Fig. 27 Generative AI in Healthcare market: Application movement analysis
  • Fig. 28 Clinical market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 29 System market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 30 Global Generative AI in Healthcare market: Regional outlook and key takeaways
  • Fig. 31 Global Generative AI in Healthcare market: Regional movement analysis
  • Fig. 32 North America market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 33 U.S. key country dynamics
  • Fig. 34 U.S. market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 35 Canada key country dynamics
  • Fig. 36 Canada market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 37 Mexico key country dynamics
  • Fig. 38 Mexico market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 39 Europe market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 40 UK key country dynamics
  • Fig. 41 UK market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 42 Germany key country dynamics
  • Fig. 43 Germany market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 44 France key country dynamics
  • Fig. 45 France market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 46 Italy key country dynamics
  • Fig. 47 Italy market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 48 Spain key country dynamics
  • Fig. 49 Spain market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 50 Denmark key country dynamics
  • Fig. 51 Denmark market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 52 Sweden key country dynamics
  • Fig. 53 Sweden market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 54 Norway key country dynamics
  • Fig. 55 Norway market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 56 Asia Pacific market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 57 Japan key country dynamics
  • Fig. 58 Japan market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 59 China key country dynamics
  • Fig. 60 China market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 61 India key country dynamics
  • Fig. 62 India market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 63 Thailand key country dynamics
  • Fig. 64 Thailand market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 65 South Korea key country dynamics
  • Fig. 66 South Korea market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 67 Australia key country dynamics
  • Fig. 68 Australia market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 69 Latin America market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 70 Brazil key country dynamics
  • Fig. 71 Brazil market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 72 Argentina key country dynamics
  • Fig. 73 Argentina market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 74 Middle East and Africa market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 75 South Africa key country dynamics
  • Fig. 76 South Africa market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 77 Saudi Arabia key country dynamics
  • Fig. 78 Saudi Arabia market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 79 UAE key country dynamics
  • Fig. 80 UAE market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 81 Kuwait key country dynamics
  • Fig. 82 Kuwait market estimates and forecasts, 2021 - 2033 (USD Million)